Consulting evaluation
Start with the problem and the evidence.
Assess Kevin for a defined advisory question, an operating assessment, or a product and program architecture engagement.
Consulting evaluation benefits from the same detail as an executive-role review: what Kevin was responsible for, the setting in which he worked, and how that experience relates to the present problem. His career combines sponsor-side clinical technology leadership, connected-health venture development, enterprise commercialization, and independent framework and publishing work.
His career chronology also records a short-term Two Impulse consulting engagement from May to December 2024. The project records below provide the more detailed evidence for evaluating a potential mandate.
Clinical technology and vendor decisions
A sponsor needs to assess a platform, vendor model, or internal delivery option.
Potential engagement focus: requirements, functional fit, integration effort, quality responsibilities, operating cost, and the service model after launch. Kevin’s prior responsibility included both regulated vendor evaluation and building an internal clinical technology organization.
Trial readiness and operational signals
A trial team needs to define what to observe, who reviews it, and what happens next.
Potential engagement focus: a pre-FPI review of signal definitions, source readiness, owners, review routines, escalation, and decision records. Trial Telemetry and the pre-FPI review are authored frameworks; their proposed application is distinguishable from Kevin’s earlier sponsor-side delivery work.
Patient-data and connected-device programs
A team needs to connect patient-generated or sensor data to a useful clinical or operational workflow.
Potential engagement focus: data paths, provenance, participant burden, site workflows, support, and the meaning of missing information. Relevant experience includes clinical informatics, connected diabetes products, and licensed Dexcom Bluetooth integration development. The Dexcom-related Rarify mobile and cloud components did not enter production but served a strategic purpose: Kevin reports approximately $150,000 in internal development created a credible replacement threat that improved performance from an approximately $2.5 million IQVIA engagement.
Patient journeys and service design
A product or care program has friction between enrollment, activation, and continuing use.
Potential engagement focus: the full participant journey, physical and digital touchpoints, home diagnostics, support, and clinician or caregiver participation. The evidence includes employer-associated programs, remote diabetes services, and population-health engagement.
Product portfolio and operating model
An organization needs a practical route from product priorities to execution.
Potential engagement focus: roadmaps, decision rights, staffing, vendor responsibilities, resource allocation, and the transition from prototype into supported use. Kevin’s Innovation Lab and enterprise commercialization work provide the operating foundation.
AI-assisted patient-data concepts
A team needs to examine a patient-narrative or AI-assisted product concept.
Potential engagement focus: consent, source attribution, provenance, user control, review responsibilities, and a bounded prototype. Relevant recent work is exploratory and framework-based; the archive describes that maturity explicitly.
Define the question
Use the context search to match a consulting brief to the archive, or contact Kevin with the decision, current constraints, stakeholders, and desired work product. Scope and deliverables can then be discussed against the relevant experience.